Trials / Completed
CompletedNCT02908152
Curcumin Supplement in Nonalcoholic Fatty Liver Patients
The Effect of Curcumin Supplement on Metabolic Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Patients
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- National Nutrition and Food Technology Institute · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effects of curcumin supplement on metabolic factors and hepatic fibrosis in nonalcoholic fatty liver patients with type 2 diabetes. Subjects will participate in 3 month, two group, randomized intervention, where one group (n=25) will take 1.5g/d curcumin and the other group (n=25) will take a placebo to compare differences in outcomes between the two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | curcumin | 1500 mg 1 capsule / day for 12 weeks |
| DIETARY_SUPPLEMENT | placebo | 1500 mg 1 capsule / day for 12 weeks |
Timeline
- Start date
- 2017-02-10
- Primary completion
- 2017-07-10
- Completion
- 2017-10-10
- First posted
- 2016-09-20
- Last updated
- 2020-09-29
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT02908152. Inclusion in this directory is not an endorsement.